Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human micro-somal protein and …
…, J Brian Houston, BG Lake, JC Lipscomb… - Current drug …, 2007 - ingentaconnect.com
Reported predictions of human in vivo hepatic clearance from in vitro data have used a variety
of values for the scaling factors human microsomal protein (MPPGL) and hepatocellularity …
of values for the scaling factors human microsomal protein (MPPGL) and hepatocellularity …
Metabolism of trichloroethylene.
…, JW Fisher, JC Lipscomb, JC Parker - Environmental health …, 2000 - ehp.niehs.nih.gov
A major focus in the study of metabolism and disposition of trichloroethylene (TCE) is to identify
metabolites that can be used reliably to assess flux through the various pathways of TCE …
metabolites that can be used reliably to assess flux through the various pathways of TCE …
Human health effects of trichloroethylene: key findings and scientific issues
…, KZ Guyton, N Keshava, JC Lipscomb… - Environmental …, 2013 - ehp.niehs.nih.gov
… Evans MV, Chiu WA, Okino MS, Caldwell JC. 2009. Development of an updated PBPK
model for trichloroethylene and metabolites in mice, and its application to discern the role of …
model for trichloroethylene and metabolites in mice, and its application to discern the role of …
Evaluation of physiologically based pharmacokinetic models for use in risk assessment
…, B Sonawane, JC Lipscomb… - Journal of Applied …, 2007 - Wiley Online Library
Physiologically based pharmacokinetic (PBPK) models are sophisticated dosimetry models
that offer great flexibility in modeling exposure scenarios for which there are limited data. …
that offer great flexibility in modeling exposure scenarios for which there are limited data. …
Covariation of human microsomal protein per gram of liver with age: absence of influence of operator and sample storage may justify interlaboratory data pooling
…, JR Harlow, JE Snawder, JC Lipscomb… - Drug Metabolism and …, 2008 - ASPET
Scaling of metabolic clearance values from liver microsomal data or recombinantly expressed
cytochrome P450 enzymes to predict human hepatic clearance requires knowledge of the …
cytochrome P450 enzymes to predict human hepatic clearance requires knowledge of the …
In vitro measurements of metabolism for application in pharmacokinetic modeling
JC Lipscomb, TS Poet - Pharmacology & therapeutics, 2008 - Elsevier
Human risk and exposure assessments require dosimetry information. Species-specific
tissue dose response will be driven by physiological and biochemical processes. While …
tissue dose response will be driven by physiological and biochemical processes. While …
Identification of developmentally toxic drinking water disinfection byproducts and evaluation of data relevant to mode of action
…, ES Hunter III, LK Teuschler, JC Lipscomb… - Toxicology and applied …, 2011 - Elsevier
Reactions between chemicals used to disinfect drinking water and compounds present in
source waters produce chemical mixtures containing hundreds of disinfection byproducts (…
source waters produce chemical mixtures containing hundreds of disinfection byproducts (…
Physiologically-based pharmacokinetic (PBPK) models in toxicity testing and risk assessment
JC Lipscomb, S Haddad, T Poet, K Krishnan - New Technologies for …, 2012 - Springer
Physiologically-based pharmacokinetic (PBPK) modeling offers a scientifically-sound framework
for integrating mechanistic data on absorption, distribution, metabolism and elimination …
for integrating mechanistic data on absorption, distribution, metabolism and elimination …
Putative mechanisms of environmental chemical–induced steatosis
JP Kaiser, JC Lipscomb… - International journal of …, 2012 - journals.sagepub.com
Liver disease is a major health issue characterized by several pathological changes, with
steatosis (fatty liver) representing a common initial step in its pathogenesis. Steatosis is of …
steatosis (fatty liver) representing a common initial step in its pathogenesis. Steatosis is of …
Interindividual variance of cytochrome P450 forms in human hepatic microsomes: correlation of individual forms with xenobiotic metabolism and implications in risk …
JE Snawder, JC Lipscomb - Regulatory Toxicology and Pharmacology, 2000 - Elsevier
Differences in biotransformation activities may alter the bioavailability or efficacy of drugs,
provide protection from certain xenobiotic and environmental agents, or increase toxicity of …
provide protection from certain xenobiotic and environmental agents, or increase toxicity of …